A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.

NCT05878522 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: sisunatovir
DRUG: placebo
DRUG: moxifloxacin
DRUG: sisunatovir

Sponsor

Pfizer